New cancer therapies target epigenetic switch

Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2, which regulates cell differentiation, identity, and plasticity, becomes dysfunctional. PRC2 has well-established links to breast, prostate, blood, and skin cancers, among others.

…